Clinical Trial Results
Showing:
All studies
[change]
Condition: Cancer
Location: Peabody, Massachusetts
25 trials found
New Search
Pan Tumor Rollover Study
RECRUITING
ASTX727 in Recurrent/Progressive Non-enhancing IDH Mutant Gliomas
RECRUITING
A Trial to Find Out if REGN5678 (Nezastomig) is Safe and How Well it Works Alone or in Combination With Cemiplimab for Adult Participants With Metastatic Castration-Resistant Prostate Cancer and Other Tumors
RECRUITING
Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial
RECRUITING
Testosterone Replacement in Male Cancer Survivors With Fatigue and Low Testosterone
RECRUITING
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
RECRUITING
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
RECRUITING
APL-101 Study of Subjects With NSCLC With c-Met EXON 14 Skip Mutations and c-Met Dysregulation Advanced Solid Tumors
RECRUITING
SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem Cells
RECRUITING
KEYMAKER-U01 Substudy 01A: Efficacy and Safety Study of Pembrolizumab (MK-3475) With or Without Chemotherapy When Used With Investigational Agents in Treatment-naïve Participants With Stage IV Non-small Cell Lung Cancer (NSCLC) (MK-3475-01A/KEYMAKER-U01A)
RECRUITING
KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
RECRUITING
JoLT-Ca Sublobar Resection (SR) Versus Stereotactic Ablative Radiotherapy (SAbR) for Lung Cancer
RECRUITING
Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment
RECRUITING
DNA Analysis of Blood and Tissue From Patients With Lung Cancer
RECRUITING
International Registry for Men With Advanced Prostate Cancer (IRONMAN)
RECRUITING
Positron Emission Tomography (PET) Imaging of Thrombosis
RECRUITING
Project: Every Child for Younger Patients With Cancer
RECRUITING
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
RECRUITING
MyVHL: Patient Natural History Study
RECRUITING
Boston Lung Cancer Study (Molecular and Genetic Analysis of Lung Cancer)
RECRUITING
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
RECRUITING
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
RECRUITING
Veterans Affairs Lung Cancer Surgery Or Stereotactic Radiotherapy
RECRUITING
RESOLVE: Abemaciclib + Letrozole +/- Metformin or Gedatolisib in Endometrial Cancer
RECRUITING